Recently, the U.S. Food and Drug Administration approved and granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula) to include a...
Pfizer introduced PfizerForAll, a user-friendly digital platform designed to make access to healthcare and managing health and wellness more seamless for people across th...
Basel, Switzerland- Roche is one step closer to gaining FDA approval for Xolair® (omalizumab). The agency accepts its supplemental Biologics License Application (sBLA) un...
Falling vaccination rates throughout Europe are leading to an increase in infections such as measles and rubella and Europe fears new epidemics. Measles viruses, for inst...
New York- Pfizer Inc. has announced promising topline data from its Phase 2b clinical trial (NCT04707313) evaluating the oral Glucagon-like peptide-1 receptor agonist (GL...
• Knee osteoarthritis is a progressive condition affecting over 360 million people worldwide and may have severe symptoms, including pain. • Grünenthal is running a gl...
A virtual marketplace leading your business into the future
